Abstract:INTRODUCTION:Hes-6 is a member of the basic helix-loop-helix (bHLH) family of transcription factors, and its overexpression has been reported in metastatic cancers of different origins. Hes-6 has been described as an inhibitor of Hes-1 during neuronal development, although its function in cancer is not known. In this study, we investigated the function of Hes-6 in breast cancer and tested the hypothesis that Hes-6 enhances breast cancer cell proliferation and is regulated by estrogen.METHODS:To investigate the function of Hes-6, T47D cells stably expressing Hes-6 were generated by lentiviral transduction, and conversely, siRNA also was used to knock down Hes-6 expression in breast cancer cells. The Hes-6-expressing T47D cells were transplanted into immunodeficient mice to study effects on tumor growth.RESULTS:We found that Hes-6 expression was significantly higher in the high-grade, estrogen receptor (ER)alpha-negative SKBR3 and MDA-MB-231 cells compared with the ERalpha-positive, non-metastasizing T47D and MCF-7 breast carcinoma cells. Moreover, the level of Hes-6 mRNA was 28 times higher in breast cancer samples compared with normal breast samples. In Hes-6-expressing T47D cells, Hes-6 ectopic expression was shown to stimulate cell proliferation in vitro as well as breast tumor growth in xenografts. Moreover, expression of Hes-6 resulted in induction of E2F-1, a crucial target gene for the transcriptional repressor Hes-1. Consistently, silencing of Hes-6 by siRNA resulted in downregulation of E2F-1 expression, whereas estrogen treatment caused induction of Hes-6 and downstream targets hASH-1 and E2F-1 in MCF-7 cells.CONCLUSIONS:Together, the data suggest that Hes-6 is a potential oncogene overexpressed in breast cancer, with a tumor-promoting and proliferative function. Furthermore, Hes-6 is a novel estrogen-regulated gene in breast cancer cells. An understanding of the role and regulation of Hes-6 could provide insights into estrogen signaling and endocrine resistance in breast cancer and, hence, could be important for the development of novel anticancer drugs.

Upregulation of HES1 Promotes Cell Proliferation and Invasion in Breast Cancer As a Prognosis Marker and Therapy Target Via the AKT Pathway and EMT Process

HES1 Overexpression Promotes Cell Proliferation and Invasion in Breast Cancer and Predicts Poor Survival

HES1 Promotes Metastasis and Predicts Poor Survival in Patients with Colorectal Cancer

HMGN5 Escorts Oncogenic STAT3 Signaling by Regulating the Chromatin Landscape in Breast Cancer Tumorigenesis

Human Homolog of Drosophila Hairy and Enhancer of Split 1, Hes1, Negatively Regulates Δ-Catenin (CTNND2) Expression in Cooperation with E2F1 in Prostate Cancer

Hes1 Promotes Cell Proliferation And Migration By Activating Bmi-1 And Pten/Akt/Gsk3 Beta Pathway In Human Colon Cancer

Function of Hes6 an Inhibitor of Hes1, in the Breast Cancer Cell Lines T47d and Mcf-7 is to Up-Regulate E2f-1 and Increased Proliferation

Prognostic Significance of Hes-1, a Downstream Target of Notch Signaling in Hepatocellular Carcinoma.

Hes-6, an Inhibitor of Hes-1, is Regulated by 17Β-Estradiol and Promotes Breast Cancer Cell Proliferation

The Expressions of Bhlh Gene HES1 and HES5 in Advanced Ovarian Serous Adenocarcinomas and Their Prognostic Significance: a Retrospective Clinical Study

HES1 promotes breast cancer stem cells by elevating Slug in triple-negative breast cancer

HEG1 indicates poor prognosis and promotes hepatocellular carcinoma invasion, metastasis, and EMT by activating Wnt/β-catenin signaling.

ESF1 and MIPEP proteins promote estrogen receptor-positive breast cancer proliferation and are associated with patient prognosis

EHD1 Promotes Breast Cancer Metastasis Through Upregulating HIF2a Expression Via Activating Mtor Pathway

HES5 Promotes Cellular Proliferation of Non-Small Cell Lung Cancer Through STAT3 Signaling

ESM1/VEGFα signaling pathway augments endothelial cell proliferation and tumor angiogenesis in human cervical squamous cell carcinoma

Expression Pattern and Clinical Significance of Hairy Enhancer of Split 1 in Colorectal Cancer

Abnormally High HIP1 Expression is Associated with Metastatic Behaviors and Poor Prognosis in ESCC

Isoproterenol-induced Upregulation of HPSE Accelerates Triple-negative Breast Cancer Cell Proliferation and Migration Through Enhancing the Transcriptional Activity of HIF-1α.

Endothelial cell-specific molecule 1 (ESM1) promoted by transcription factor SPI1 acts as an oncogene to modulate the malignant phenotype of endometrial cancer

Protease Nexin I is a feedback regulator of EGF/PKC/MAPK/EGR1 signaling in breast cancer cells metastasis and stemness